Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Dougados

Showing results (401-410 of 600) with videos related to

Pageof 60
Sort By:
Arthritis and Rheumatism|August 31, 2004
What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filterAstrid J B Wanders, Robert B M Landewé, Anneke Spoorenberg, et al.
Arthritis Research & Therapy|November 17, 2015
Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis populationMichael E Weinblatt, Roy Fleischmann, Ronald F van Vollenhoven, et al.
Annals of the Rheumatic Diseases|July 8, 2017
Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohortMaxime Dougados, Alexandre Sepriano, Anna Molto, et al.
Arthritis Research & Therapy|January 17, 2014
Efficacy of anakinra in gouty arthritis: a retrospective study of 40 casesSébastien Ottaviani, Anna Moltó, Hang-Korng Ea, et al.
Joint Bone Spine|June 27, 2006
Recommendations of the French Society for Rheumatology. TNFalpha antagonist therapy in rheumatoid arthritisBruno Fautrel, Arnaud Constantin, Jacques Morel, et al.
Seminars in Arthritis and Rheumatism|April 10, 2020
Effects of successive switches to different biosimilars infliximab on immunogenicity in chronic inflammatory diseases in daily clinical practiceAmbre Lauret, Anna Moltó, Vered Abitbol, et al.
Arthritis Care & Research|October 10, 2014
Efficacy and safety of rituximab in elderly patients with rheumatoid arthritis enrolled in a French Society of Rheumatology registrySarah Payet, Martin Soubrier, Elodie Perrodeau, et al.
The Journal of Rheumatology|September 6, 2005
Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanerceptJohn C Davis, Désirée M F M Van der Heijde, Maxime Dougados, et al.
Joint Bone Spine|November 27, 2007
Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritisBruno Fautrel, Thao Pham, Gaël Mouterde, et al.
Rheumatology (Oxford, England)|January 30, 2016
Effectiveness and safety of abatacept in elderly patients with rheumatoid arthritis enrolled in the French Society of Rheumatology's ORA registryClément Lahaye, Martin Soubrier, Aurélien Mulliez, et al.
Pageof 60

Showing results (401-410 of 600) with videos related to

Sort By:
Pageof 60
Arthritis and Rheumatism|August 31, 2004
What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filterAstrid J B Wanders, Robert B M Landewé, Anneke Spoorenberg, et al.
Arthritis Research & Therapy|November 17, 2015
Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis populationMichael E Weinblatt, Roy Fleischmann, Ronald F van Vollenhoven, et al.
Annals of the Rheumatic Diseases|July 8, 2017
Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohortMaxime Dougados, Alexandre Sepriano, Anna Molto, et al.
Arthritis Research & Therapy|January 17, 2014
Efficacy of anakinra in gouty arthritis: a retrospective study of 40 casesSébastien Ottaviani, Anna Moltó, Hang-Korng Ea, et al.
Joint Bone Spine|June 27, 2006
Recommendations of the French Society for Rheumatology. TNFalpha antagonist therapy in rheumatoid arthritisBruno Fautrel, Arnaud Constantin, Jacques Morel, et al.
Seminars in Arthritis and Rheumatism|April 10, 2020
Effects of successive switches to different biosimilars infliximab on immunogenicity in chronic inflammatory diseases in daily clinical practiceAmbre Lauret, Anna Moltó, Vered Abitbol, et al.
Arthritis Care & Research|October 10, 2014
Efficacy and safety of rituximab in elderly patients with rheumatoid arthritis enrolled in a French Society of Rheumatology registrySarah Payet, Martin Soubrier, Elodie Perrodeau, et al.
The Journal of Rheumatology|September 6, 2005
Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanerceptJohn C Davis, Désirée M F M Van der Heijde, Maxime Dougados, et al.
Joint Bone Spine|November 27, 2007
Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritisBruno Fautrel, Thao Pham, Gaël Mouterde, et al.
Rheumatology (Oxford, England)|January 30, 2016
Effectiveness and safety of abatacept in elderly patients with rheumatoid arthritis enrolled in the French Society of Rheumatology's ORA registryClément Lahaye, Martin Soubrier, Aurélien Mulliez, et al.
Pageof 60